FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bo von Schoultz

Research Profile

Procedures

Anatomy

Breast

Physiology

Postmenopause

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Marika Christina Möller; Angelique Flöter Rådestad; Bo von Schoultz; Aniko Bartfai
Effect of estrogen and testosterone replacement therapy on cognitive fatigue.
Ljiljana Kocoska-Maras; Angelique Flöter Rådestad; Bo von Schoultz; Torbjörn Bäckström; Kjell Carlström; Angelica Lindén Hirschberg
Cognitive function in association with sex hormones in postmenopausal women.
Huong T T Nguyen; Tuan V Nguyen; Vu T Thuy; Bo von Schoultz; Pham T M Duc; Dang N Dzung; Angelica L Hirschberg
Vitamin D deficiency in northern Vietnam: prevalence, risk factors and associations with bone mineral density.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bo von Schoultz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marika Christina Möller; Angelique Flöter Rådestad; Bo von Schoultz; Aniko Bartfai
Effect of estrogen and testosterone replacement therapy on cognitive fatigue.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2013;29(2):173-6.
2013: Ljiljana Kocoska-Maras; Angelique Flöter Rådestad; Bo von Schoultz; Torbjörn Bäckström; Kjell Carlström; Angelica Lindén Hirschberg
Cognitive function in association with sex hormones in postmenopausal women.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2013;29(1):59-62.
2012: Huong T T Nguyen; Tuan V Nguyen; Vu T Thuy; Bo von Schoultz; Pham T M Duc; Dang N Dzung; Angelica L Hirschberg
Vitamin D deficiency in northern Vietnam: prevalence, risk factors and associations with bone mineral density.
Bone 2012;51(6):1029-34.
2012: Huong Tt Nguyen; Tuan V Nguyen; Mo Pourian; Bo von Schoultz; Birgitta Bystrom; Ingrid Dahlin; Pham Tm Duc; Angelica L Hirschberg
Low aglycone content in commercial soy drink products.
Asia Pacific journal of clinical nutrition 2012;21(1):52-6.
2011: Ljiljana Kocoska-Maras; Niklas Zethraeus; Angelique Flöter Rådestad; Tore Ellingsen; Bo von Schoultz; Magnus Johannesson; Angelica Lindén Hirschberg
A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women.
Fertility and sterility 2011;95(1):152-7.
2009: Susan R Davis; Angelica Lindén Hirschberg; Leigh K Wagner; Imran Lodhi; Bo von Schoultz
The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy.
The Journal of clinical endocrinology and metabolism 2009;94(12):4907-13.
2009: Bo von Schoultz
Oestrogen therapy: oral versus non-oral administration.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009;25(9):551-3.
2009: Bo von Schoultz
[Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
Läkartidningen 2009;106(34):2041-2.
2009: Niklas Zethraeus; Ljiljana Kocoska-Maras; Tore Ellingsen; Bo von Schoultz; Angelica Lindén Hirschberg; M Johannesson
A randomized trial of the effect of estrogen and testosterone on economic behavior.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(16):6535-8.
2009: Peter Kenemans; Nigel J Bundred; Jean-Michel Foidart; Ernst Kubista; Bo von Schoultz; Piero Sismondi; Rena Vassilopoulou-Sellin; Cheng Har Yip; Jan Egberts; Mirjam Mol-Arts; Roel Mulder; Steve van Os; Matthias W Beckmann
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
The lancet oncology 2009;10(2):135-46.
2009: Marie Hofling; L Ma; Lena Sahlin; C Haglund; S Nordling; Bo von Schoultz; J Mark Cline
Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys.
Climacteric : the journal of the International Menopause Society 2009;12(1):72-9.
2008: L Ma; Marie Hofling; Britt Masironi; Bo von Schoultz; J Mark Cline; Lena Sahlin
Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Maturitas 2008;61(4):345-9.
2008: Bo von Schoultz
New perspectives in breast cancer diagnosis.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2008;24(11):610.
2008: Peter Conner; Eva Lundström; Bo von Schoultz
Breast cancer and hormonal therapy.
Clinical obstetrics and gynecology 2008;51(3):592-606.
2007: L Lofgren; L Sahlin; S Jiang; Bo von Schoultz; R Fernstad; Lambert Skoog; Eva von Schoultz
Expression of syndecan-1 in paired samples of normal and malignant breast tissue from postmenopausal women.
Anticancer research 2007;27(5A):3045-50.
2007: Eva Lundström; M Bygdeson; Gunilla Svane; Edward Azavedo; Bo von Schoultz
Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
Climacteric : the journal of the International Menopause Society 2007;10(3):249-56.
2007: Bo von Schoultz
Androgens and the breast.
Maturitas 2007;57(1):47-9.
2007: Marie Hofling; Eva Lundström; Edward Azavedo; Gunilla Svane; Angelica Lindén Hirschberg; Bo von Schoultz
Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
Climacteric : the journal of the International Menopause Society 2007;10(2):155-63.
2007: Marie Hofling; Angelica Lindén Hirschberg; Lambert Skoog; Edneia Tani; Torsten Hägerström; Bo von Schoultz
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Menopause (New York, N.Y.) 2007;14(2):183-90.
2007: Helenius J Kloosterboer; Lars Löfgren; Eva von Schoulz; Bo von Schoultz; H A M Verheul
Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Reproductive sciences (Thousand Oaks, Calif.) 2007;14(2):151-9.
2007: Angelica Lindén Hirschberg; Måns Gustaf Edlund; Gunilla Svane; Edward Azavedo; Lambert Skoog; Bo von Schoultz
An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
Menopause (New York, N.Y.) 2007;14(1):89-96.
2006: Eva Lundström; L Sahlin; Lambert Skoog; Torsten Hägerström; Gunilla Svane; Edward Azavedo; K Sandelin; Bo von Schoultz
Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density.
Climacteric : the journal of the International Menopause Society 2006;9(4):277-82.
2006: Lars Löfgren; Eva von Schoultz; R Fernstad; Bo von Schoultz; Kjell Carlström
Are estrogen receptor content in breast cancer and effects of tamoxifen on sex hormone-binding globulin markers for individual estrogen sensitivity?
The Journal of steroid biochemistry and molecular biology 2006;99(1):76-9.
2006: Eva Lundström; Gunnar Söderqvist; Gunilla Svane; Edward Azavedo; Matts Olovsson; Lambert Skoog; Eva von Schoultz; Bo von Schoultz
Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
Fertility and sterility 2006;85(4):989-95.
2006: Lars Löfgren; Lena Sahlin; Bo von Schoultz; R Fernstad; Lambert Skoog; Eva von Schoultz
Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal women.
Acta oncologica (Stockholm, Sweden) 2006;45(1):54-60.
2005: Peter Conner; Thomas C Register; Lambert Skoog; Edneia Tani; Bo von Schoultz; J Mark Cline
Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.
American journal of obstetrics and gynecology 2005;193(1):58-63.
2005: Jörgen Nathorst-Böös; Maria Jarkander-Rolff; Kjell Carlström; Angelique Flöter; Bo von Schoultz
Percutaneous administration of testosterone gel in postmenopausal women--a pharmacological study.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2005;20(5):243-8.
2005: Marie Hofling; Kjell Carlström; Gunilla Svane; Edward Azavedo; Helenius Kloosterboer; Bo von Schoultz
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2005;20(2):110-5.
2004: Gunnar Söderqvist; Bo von Schoultz
Lessons to be learned from clinical studies on hormones and the breast.
Maturitas 2004;49(1):90-6.
2004: Anette Rickenlund; Kjell Carlström; Björn Ekblom; Torkel B Brismar; Bo von Schoultz; Angelica Lindén Hirschberg
Effects of oral contraceptives on body composition and physical performance in female athletes.
The Journal of clinical endocrinology and metabolism 2004;89(9):4364-70.
2004: Peter Conner; Gunilla Svane; Edward Azavedo; Gunnar Söderqvist; Kjell Carlström; Thomas Gräser; Friedrich Walter; Bo von Schoultz
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
Fertility and sterility 2004;81(6):1617-23.
2004: Peter Conner; Alexander Christow; W Kersemaekers; Gunnar Söderqvist; Lambert Skoog; Kjell Carlström; Edneia Tani; M Mol-Arts; Bo von Schoultz
A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
Climacteric : the journal of the International Menopause Society 2004;7(1):50-8.
2004: Angelique Flöter; Jörgen Nathorst-Böös; Kjell Carlström; Bo von Schoultz
Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy.
Maturitas 2004;47(2):123-9.
2004: Anette Rickenlund; Marja Thorén; Kjell Carlström; Bo von Schoultz; Angelica Lindén Hirschberg
Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes.
The Journal of clinical endocrinology and metabolism 2004;89(2):702-7.
2004: Lars Löfgren; Birgitta Wallberg; Nils Wilking; Tommy Fornander; Lars Erik Rutqvist; Kjell Carlström; Bo von Schoultz; Eva von Schoultz
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids.
Medical oncology (Northwood, London, England) 2004;21(4):309-18.
2003: Bo von Schoultz
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
Climacteric : the journal of the International Menopause Society 2003;6 Suppl 2():24-32.
2003: Lars Löfgren; Lambert Skoog; Eva von Schoultz; Edneia Tani; Erika Isaksson; R Fernstad; Kjell Carlström; Bo von Schoultz
Hormone receptor status in breast cancer--a comparison between surgical specimens and fine needle aspiration biopsies.
Cytopathology : official journal of the British Society for Clinical Cytology 2003;14(3):136-42.
2003: Erika Isaksson; Hong Wang; Lena Sahlin; Bo von Schoultz; J Mark Cline; Eva von Schoultz
Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques.
Breast cancer research and treatment 2003;79(2):233-9.
2003: Anette Rickenlund; Kjell Carlström; Björn Ekblom; Torkel B Brismar; Bo von Schoultz; Angelica Lindén Hirschberg
Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance.
Fertility and sterility 2003;79(4):947-55.
2003: Peter Conner; Gunnar Söderqvist; Lambert Skoog; Thomas Gräser; Friedrich Walter; Edneia Tani; Kjell Carlström; Bo von Schoultz
Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Breast cancer research and treatment 2003;78(2):159-65.
2003: Hong Wang; Erika Isaksson; Bo von Schoultz; J Mark Cline; Lena Sahlin
Effect of long-term treatment with steroid hormones or tamoxifen on the progesterone receptor and androgen receptor in the endometrium of ovariectomized cynomolgus macaques.
Reproductive biology and endocrinology : RB&E 2003;1():7.
2002: Angelique Flöter; Jörgen Nathorst-Böös; Kjell Carlström; Bo von Schoultz
Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
Climacteric : the journal of the International Menopause Society 2002;5(4):357-65.
2002: Hong Wang; Erika Isaksson; Bo von Schoultz; J Mark Cline; Lena Sahlin
The effect of long-term treatment with steroid hormones or tamoxifen on oestrogen receptors (alpha and beta) in the endometrium of ovariectomized cynomolgus macaques.
The Journal of endocrinology 2002;175(3):673-81.
2002: Bo von Schoultz
[Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
Läkartidningen 2002;99(34):3276-8.
2002: Erika Isaksson; Hong Wang; Lena Sahlin; Bo von Schoultz; Britt Masironi; Eva von Schoultz; J Mark Cline
Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen.
Breast (Edinburgh, Scotland) 2002;11(4):295-300.
2002: Eva Lundström; Alexander Christow; Wendy Kersemaekers; Gunilla Svane; Edward Azavedo; Gunnar Söderqvist; Mirjam Mol-Arts; Jan Barkfeldt; Bo von Schoultz
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
American journal of obstetrics and gynecology 2002;186(4):717-22.
2002: Ian Milsom; Viveca Odlind; Bo von Schoultz; Ingrid Ostlund; Elisabeth Persson
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Läkartidningen 2002;99(1-2):10-2, 15.
2001: Eva Lundström; B Wilczek; Z von Palffy; Gunnar Söderqvist; Bo von Schoultz
Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Climacteric : the journal of the International Menopause Society 2001;4(1):42-8.
2001: Bo von Schoultz
["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered].
Läkartidningen 2001;98(5):412-6.
2001: Erika Isaksson; Eva von Schoultz; Viveca Odlind; Gunnar Söderqvist; G Csemiczky; Kjell Carlström; Lambert Skoog; Bo von Schoultz
Effects of oral contraceptives on breast epithelial proliferation.
Breast cancer research and treatment 2001;65(2):163-9.
2001: J Mark Cline; Gunnar Söderqvist; Thomas C Register; J K Williams; Michael R Adams; Bo von Schoultz
Assessment of hormonally active agents in the reproductive tract of female nonhuman primates.
Toxicologic pathology 2001;29(1):84-90.
2000: Angelique Flöter; Kjell Carlström; Bo von Schoultz; Jörgen Nathorst-Böös
Administration of testosterone undecanoate in postmenopausal women: effects on androgens, estradiol, and gonadotrophins.
Menopause (New York, N.Y.) 2000;7(4):251-6.
2000: I Milsom; Viveca Odlind; K Andersson; Bo von Schoultz; B L Axelson
Should profitability determine the availability of effective contraception?
Lancet 2000;355(9218):1914-5.
2000: Bo von Schoultz; L Bergkvist; C Magnusson; Eva von Schoultz
[Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
Läkartidningen 2000;97(18):2225-6.
2000: I Milsom; I Ostlund; Viveca Odlind; K Andersson; Bo von Schoultz
[Production of the most efficient copper intrauterine device has ceased: Will the profit determine women's access to safe contraception?].
Läkartidningen 2000;97(14):1721-2, 1725.
1999: Erika Isaksson; Lena Sahlin; Gunnar Söderqvist; Eva von Schoultz; Britt Masironi; M Wickman; Nils Wilking; Bo von Schoultz; Lambert Skoog
Expression of sex steroid receptors and IGF-1 mRNA in breast tissue--effects of hormonal treatment.
The Journal of steroid biochemistry and molecular biology 1999;70(4-6):257-62.
1999: Eva Lundström; B Wilczek; Z von Palffy; Gunnar Söderqvist; Bo von Schoultz
Mammographic breast density during hormone replacement therapy: differences according to treatment.
American journal of obstetrics and gynecology 1999;181(2):348-52.
1999: Erika Isaksson; J Mark Cline; Lambert Skoog; Gunnar Söderqvist; Nils Wilking; Eva von Schoultz; Bo von Schoultz
p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques.
Breast cancer research and treatment 1999;53(1):61-7.
1998: J Mark Cline; G Soderqvist; Eva von Schoultz; Lambert Skoog; Bo von Schoultz
Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques.
Breast cancer research and treatment 1998;48(3):221-9.
1998: Gunnar Söderqvist; Matti Poutanen; M Wickman; Bo von Schoultz; Lambert Skoog; RK Vihko
17Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception.
The Journal of clinical endocrinology and metabolism 1998;83(4):1190-3.
1997: A Lindén Hirschberg; C Lindholm; Bo von Schoultz
Reduced meal-related gastrointestinal hormone response to adrenocorticotropic hormone stimulation test in female athletes.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1997;11(2):83-9.
1997: Bo von Schoultz
HRT and breast cancer risk, what to advise?
European journal of obstetrics, gynecology, and reproductive biology 1997;71(2):205-8.
1997: J Mark Cline; Gunnar Söderqvist; Bo von Schoultz; Lambert Skoog
Regional distribution of proliferating cells and hormone receptors in the mammary gland of surgically postmenopausal macaques.
Gynecologic and obstetric investigation 1997;44(1):41-6.
1997: Gunnar Söderqvist; Erika Isaksson; Bo von Schoultz; Kjell Carlström; Edneia Tani; Lambert Skoog
Proliferation of breast epithelial cells in healthy women during the menstrual cycle.
American journal of obstetrics and gynecology 1997;176(1 Pt 1):123-8.
1996: Bo von Schoultz; Gunnar Söderqvist; M Cline; Eva von Schoultz; Lambert Skoog
Hormonal regulation of the normal breast.
Maturitas 1996;23 Suppl():S23-5.
1996: J Mark Cline; G Soderqvist; Eva von Schoultz; Lambert Skoog; Bo von Schoultz
Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques.
American journal of obstetrics and gynecology 1996;174(1 Pt 1):93-100.
1995: C Lindholm; A L Hirschberg; Kjell Carlström; Bo von Schoultz
Altered adrenal steroid metabolism underlying hypercortisolism in female endurance athletes.
Fertility and sterility 1995;63(6):1190-4.
1995: L Skjöldebrand Sparre; A Carlström; Bo von Schoultz; Kjell Carlström
Serum levels of androgens and estrogens and 'steroid-sensitive' liver proteins in early human pregnancy: influence on the gender of the offspring.
Gynecologic and obstetric investigation 1995;40(3):145-50.
1994: S Stock; R Karlsson; Bo von Schoultz
Serum profiles of oxytocin during oral contraceptive treatment.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1994;8(2):121-6.
1994: Eva von Schoultz; Nils Wilking; Lars Erik Rutqvist; T Theve; Bo von Schoultz
[Estrogen therapy. Is breast cancer a contraindication to hormonal substitution therapy?].
Läkartidningen 1994;91(13):1302-6.
1994: Gunnar Söderqvist; H Olsson; Nils Wilking; Bo von Schoultz; Kjell Carlström
Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
The Journal of steroid biochemistry and molecular biology 1994;48(2-3):221-4.
1994: A L Hirschberg; C Lindholm; Kjell Carlström; Bo von Schoultz
Reduced serum cholecystokinin response to food intake in female athletes.
Metabolism: clinical and experimental 1994;43(2):217-22.
1993: L Sylvén; C Magnusson; K Hagenfeldt; Bo von Schoultz
Life with Turner's syndrome--a psychosocial report from 22 middle-aged women.
Acta endocrinologica 1993;129(3):188-94.
1993: Gunnar Söderqvist; Bo von Schoultz; E Tani; Lambert Skoog
Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):874-9.
1993: C Lindholm; A L Hirschberg; Kjell Carlström; Bo von Schoultz
Hormone anabolic/catabolic balance in female endurance athletes.
Gynecologic and obstetric investigation 1993;36(3):176-80.
1992: P Henriksson; Reinhard Stege; L Collste; Ake Pousette; Bo von Schoultz; Kjell Carlström
[Parenteral estrogen--a safe therapeutic alternative in prostatic cancer seen from the cardiovascular point of view?].
Läkartidningen 1992;89(42):3493-4, 3497.
1991: L Sylvén; K Hagenfeldt; K Bröndum-Nielsen; Bo von Schoultz
Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life.
Acta endocrinologica 1991;125(4):359-65.
1989: Reinhard Stege; Kjell Carlström; L Collste; A Eriksson; Peter Henriksson; Ake Pousette; Bo von Schoultz
Single-drug parenteral estrogen treatment in prostatic cancer: a study of two maintenance-dose regimens.
The Prostate 1989;14(2):183-8.
1989: Bo von Schoultz; Kjell Carlström; L Collste; A Eriksson; Peter Henriksson; Ake Pousette; Reinhard Stege
Estrogen therapy and liver function--metabolic effects of oral and parenteral administration.
The Prostate 1989;14(4):389-95.
1989: Kjell Carlström; A Lagrelius; NO Lunell; G Möllerström; G Rannevik; Bo von Schoultz
Dehydroepiandrosterone sulfate in postmenopausal women: lack of influence of parity.
Gynecologic and obstetric investigation 1989;28(1):35-7.
1989: Kjell Carlström; L Collste; A Eriksson; Peter Henriksson; Ake Pousette; Reinhard Stege; Bo von Schoultz
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy.
The Prostate 1989;14(2):177-82.
1988: Kjell Carlström; S Brody; NO Lunell; A Lagrelius; G Möllerström; Ake Pousette; G Rannevik; R Stege; Bo von Schoultz
Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex.
Maturitas 1988;10(4):297-306.
1988: L S Sparre; J Brundin; A Carlström; Bo von Schoultz; Kjell Carlström
Serum levels of estrogens and of five 'steroid sensitive' proteins in early normal pregnancy.
Acta endocrinologica 1988;118(2):239-44.
1988: Peter Henriksson; A Eriksson; Reinhard Stege; L Collste; Ake Pousette; Bo von Schoultz; Kjell Carlström
Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.
The Prostate 1988;13(3):257-61.